diagnostic test khalid (p i h)

Upload: mayxzine

Post on 07-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    1/17

    DIAGNOSTIC TEST PURPOSE NORMAL VALUES SIGNIFICANCE NURSINGCONSIDERATIO

    NS

    BLOOD UREANITROGEN

    -To evaluate kidneyfunction and aid inthe diagnosis of renaldisease

    -To aid in the assessof hydration

    -8 to 20 mg/dl

    Abnormal Results:

    -Elevated levels:renal disease,reduced renal bloodflow (e.g. caused bydehydration),urinary tractobstruction, andincreased protein

    catabolism (such asburns)

    -Low levels: suggestsevere hepaticdamage,malnutrition, andover hydration

    -Apply directpressure to thebleeding site.

    -Inform thepatient that hemay resumetaking his usual

    medications afterthe test.

    -To evaluate liverfunction

    To aid in thedifferential diagnosisof jaundice andmonitor its progress

    -In adults, normal indirectserum bilirubin levels are1.1 mg/dl (SI, 19umol/L)

    Abnormal Results:

    -Elevated indirectserum bilirubinlevels usuallyindicate hepaticdamage

    -High levels of

    -Apply directpressure to thevenipuncture siteto stop bleeding.

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    2/17

    BILIRUBIN, SERUM,DIRECT ANDINDIRECT

    -To aid in thediagnosis of biliaryobstruction andhemolytic anemia

    -To determinewhether a neonaterequires anexchange transfusionor phototherapybecause of dangerously highunconjugatedbilirubin levels

    indirect bilirubin arealso likely in severehemolytic anemia

    -If hemolysis

    continues, directand indirect bilirubinlevels may rise

    -Other causes ofelevated indirectbilirubin levelsinclude congenitalenzyme deficienciessuch as GilbertsyndromeElevated directserum bilirubinlevels usuallyindicate biliaryobstruction

    -If obstructioncontinues, directand indirect bilirubin

    levels may rise

    -In severe chronichepatic damage,direct bilirubinconcentrations mayreturn to normal ornear normal levels,but indirect bilirubinlevels remain

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    3/17

    elevatedthan 0.5mg/dl(SI,

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    4/17

    function disorders intravascularcoagulation,hemolytic disease ofthe newborn,schonlein-henoch

    purpura, severehepatic disease(cirrhosis, forexample), or severedeficiency of factorsI,II,V,VII,VIII,IX, andXI.

    48 hours toprevent furtherbleeding.

    -Check the test

    area frequently;keep the edgesof the cutsaligned tominimizescarring.

    -Instruct thepatient thathe/she mayresume his/hermedication afterthe tests

    HEMATOCRIT

    -To aid diagnosis ofpolycythemia,anemia, or abnormalstates of hydration

    -To aid in thecalculation of erythrocyte indices

    -HCT is usually measuredelectronically; electronicresults are 3% lower thanmanual measurements

    which trap plasma in thecolumn of packet RBCs

    -In men, 42% to 52% (SI, .42 to 0.52)

    -In women, 36% to 48%(SI, 0.36 to 0.48)

    Abnormal Results:

    -Low HCT suggestsanemia,hemodilution, ormassive blood loss

    -High HCT indicatespolycythemia orhemoconcentrationcaused by blood lossand dehydration.

    -Ensuresubdermalbleeding hasstopped before

    removingpressure

    -If largehematomadevelops at thevenipuncturesite, monitordistal pulses.

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    5/17

    UNSTABLEHEMOGLOBIN

    -To detect of hemoglobin.

    -Heat stability test result isnegative, isopropanol

    solubility test result isstable

    Abnormal Results:

    -A positive heatstability test result

    or unstable,solubility test result,especially withhemolysis, stronglysuggest thepresence of unstable Hb.

    -Make sure thesubdermal

    bleeding hasstopped beforeremovingpressure

    -Instruct thepatient that hemay resumemedicationsstopped beforethe test.

    -If a largehematomadevelops at thevenipuncturesite, monitorpulses distal tothe site.

    PLATELET COUNT

    -To evaluate plateletproduction

    -To assess theeffects of chemotherapy orradiation therapy onplatelet production

    Adults: 140,000 to400,000/ul (SI, 140 to400x10/L)

    Abnormal Results:

    -A count below50,000/ul can causespontaneousbleeding, when thecount is below5,000/ul, fatalcentral nervoussystem bleeding ormassive GI

    -Make sure thatsubdermalbleeding hasstopped beforeremovingpressure

    -Tell the patientthat he may

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    6/17

    -To diagnose andmonitor severethrombocytosis orthrombocytopenia.

    hemorrhage ispossible

    -A decreased count(thrombocytopenia,

    80 to 100 millionplatelets per ml) canresult from aplasticor hypoplastic bonemarrow; infiltrativebone marrowdisease, such asleukemia, ordisseminatedinfection.

    -An increased count(thrombocytosis canresult fromhemorrhage,infectious disorders,iron deficiencyanemia, recentsurgery, pregnancy,splenectomy orinflammatorydisorders. In suchcases, the plateletcount returns tonormal after thepatient recoversfrom the primarydisorder

    resume anymedicationsstopped beforethe test

    -If a largehematomadevelops,monitor pulsesdistal to thevenipuncture site

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    7/17

    PROTHROMBINTIME

    -To evaluate theextrinsic coagulation

    system (factors V,VII,and prothrombin andfibrinogen)

    -To monitor responseto oral anticoagulanttherapy

    -PT should be 10-14seconds (SI. 10 to 14s)

    depending on the sourceof tissue thromboplastinand the type of sensingdevices used to measureclot formation

    -In a patient receiving oralanticoagulants, PT shouldbe from 1 to 2 times thenormal control value

    Abnormal Results:

    -Prolonged PT mayindicate deficiencies

    in fibrinogen,prothrombin, factorsV, VII, or X (specificassays can pinpointsuch deficiencies),or vitamin K. it mayalso result fromongoing oralanticoagulanttherapy

    -A prolonged PT thatexceeds 2 timesthe control valueusually indicatesabnormal bleeding

    -Make suresubdermal

    bleeding hasstopped beforeremovingpressure

    -Instruct thepatient that hemay resume hisusual diet andmedicationsdiscontinuedbefore the test

    -If a largehematomadevelops at thevenipuncturesite, monitorpulses distal tothe site.

    URIC ACID, URINE

    -To detect enzymedeficiencies andmetabolicdisturbances (suchas gout) that affecturic acid production

    -250 to 750 mg/24 hours(SI, 1.48 to 4.43 mmol/d),depending on patientsdiet.

    Abnormal Results:

    -Increased levelsmay result fromchronic myeloidleukemia,polycythemia, vera,multiple myeloma,

    -Instruct thepatient that hemay resume hisusual diet andmedications.

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    8/17

    -To help measure theefficiency of renalclearance and todetermine the risk of

    stone formation

    early remision inpernicious anemia,lymphosarcoma andlymphatic leukemiaduring radiotherapy,

    or tubularreabsorptiondefects, such asfanconis syndromeand hepatolenticulardegeneration

    -Decreased levelsoccur in gout (whenuric acid productionin normal butexcretioninadequate) and insevere renaldamage such asthat resulting fromchronicglorulonephritis,diabeticglomerulosclerosis,and collagendisorders

    Nonstress, Fetal(NST, Fetal ActivityDetermination)

    -The NST is amethod to evaluatethe viability of afetus. It documentsthe placentas abilityto provide an

    -Explain theprocedure to theclient.

    -Encourage theverbalization of

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    9/17

    adequate bloodsupply to the fetus.The NST can be usedto evaluate any high-risk pregnancy in

    which fetal well-being may bethreatened. Thesepregnancies includesthose marked bydiabetes,hypertensive diseaseof pregnancy(toxemia),intrauterine growthretardation, Rh-factorsensitization, historyof stillbirth,postmaturity, or lowestriol levels.

    the patientsfears. Thenecessity for thestudy usuallyraises realistic

    fears in theexpectantmother.

    -If the patient ishungry, instructher to eat beforethe NST is begun.Fetal activity isenhanced with ahigh maternalserum glucoselevel.

    During-After the patientempties herbladder, placeher in the Simsposition.-Place anexternal fetalmonitor on thepatientsabdomen torecord the FHR. The mother canindicate fetalmovement bypressing a buttonon the fetal

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    10/17

    monitorwhenever shefeels the fetusmove.

    -The FHR andfetal movementareconcomitantlyrecorded on atwo-channel stripgraph.

    -Observe thefetal monitor forFHRaccelerationsassociated withfetal movement.

    -If the fetus isquiet for 20minutes,stimulate fetalactivity byexternalmethods, such asrubbing orcompressing themothersabdomen, ringinga bell near theabdomen, orplacing the panon the abdomenand hitting the

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    11/17

    pan.

    -Note that anurse performsthe NST in

    approximately 20to 40 minutes inthe physiciansoffice or ahospital unit.

    -Tell the patientthat nodiscomfort isassociated withthe NST.

    After-If the resultsdetect anonreactivefetus, calmlyinform thepatient that sheis a candidate forthe CST.

    SERUM URIC ACID-To confirm thediagnosis of gout

    -To help detect renaldysfunction

    In men, 3.4 to 7 mg/dlIn women,2.3 to 6 mg/dl

    Abnormal Results:

    -Increased uric acidlevels may indicategout or impairedkidney functions.

    -Apply directpressure to thevenipuncture siteuntil bleedingstops.

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    12/17

    -Levels may alsorise in heart failure,glycogen storagedisease (type 1 vonGierkes disease),

    infection, hemolyticand sickle cellanemia,polycythemia,neoplasms, andpsoriasis

    -Low uric acid levelsmay indicatedefective tubularabsorption such as

    acute hepaticatrophy.

    -Inform thepatient that hemay resume heusual diet and

    medicationsstopped beforethe test.

    Urinalysis (UA)

    -To screen thepatients urine forthe renal or urinarytract disease

    -To help detectmetabolic orsystemic diseaseunrelated to renaldisorder

    -To detectsubstances (drugs)

    Color: straw to dark yellowOdor: slightly aromaticAppearance: clearSpecific gravity: 100

    Protein- 0-8 mg/dl- 50-80

    mg/24 hr (at rest)-

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    13/17

    erythematosus

    Goodpastures syndrome

    Heavy-metalpoisoning

    Bacterialpyelonephritis

    Nephrotoxicdrug therapy

    Renal diseaseinvolving theglomeruli isassociatedwith

    proteinuria.

    Trauma.Protein can spillinto the urineas a result oftraumaticdestruction ofthe blood-urine barrier.

    Macroglobulin

    emia. Withincreasedglobulinwithin theblood,albumin issecreted in anattempt to tomaintain

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    14/17

    ocncotichomeostasis.

    Multiplemyelomas.Classically,

    mulptiplemyelomasproduce largeamounts ofprotein (e.g.,Bence-Jonesprotein) in theurine.

    Preeclampsia

    Congestive

    heart failure The

    pathophysiologic factors oftheseobservationsare many.Suffice it tosay thatalbumin leaksfrom the

    glomeruli,which aretemporarilydamage bythis illnesses.

    Orthostaticproteinuria.As many as20% of normal male

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    15/17

    patients havesmallamounts ofprotein in theurine when

    urinespecimensare obtainedfrom patientsin the uprightposition. Thepathophysiology is notknown withcertainty. Itmay be

    associatedwith passivecongestion ofkidney in theuprightposition. Thisphenomenonis can bediagnosed byobtaining aurinespecimenbefore arisingand anotherafter thepatient hasbeen up fortwo hours. The first hasno protein,

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    16/17

    the latterdoes.

    Severemuscleexertion.

    Prolongedmuscularexertion canbe associatedwith smallamount of protein in theurine.

    Renal veinthrombosis.Congestion ofthe kidney isassociatedwithproteinuria.

    Bladdertumors.Tumors of thebladdersecreteprotein into

    the lumen ofthe bladder.

    Urethritis orprostatitis.Inflammationin theperiurethralglands orurethra cancause

  • 8/6/2019 Diagnostic Test Khalid (p i h)

    17/17

    proteinuria.

    Amyloidosis.Oftenassociatedwith

    proteinuria, itmay be osevere as tocausenephriticsyndrome.Usually,amyloidosis ofthe kidney isdue to othersevere,ongoingdisease.